AllMind

The AI-powered financial markets research terminal for institutional investors.

Stay Updated

Aeon Biopharma director Timothy Lynch buys $243,455 in stock | AllMind AI News

Aeon Biopharma director Timothy Lynch buys $243,455 in stock

August 22, 2026

Article content was unavailable (received HTTP 403), so no news substance could be extracted for financial analysis.

Article content was unavailable (received HTTP 403), so no news substance could be extracted for financial analysis.

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Overall Sentiment

neutral

Sentiment Score

0.00

Trade Breakdown Deepens US Canada RiftAugust 22, 2026
Why XRP Is Skyrocketing This WeekAugust 22, 2026
World Bank projects war-hit Lebanon’s economy to contract by 6.4 percentAugust 22, 2026
Investing in AI for More Jobs, Less PayAugust 22, 2026
These stocks are most overbought even as the S&P 500 posts a losing weekAugust 22, 2026
Warren Buffett's Last Warning About the Stock Market Could Haunt Wall Street for Years. History Says This Will Happen Next.August 22, 2026